Our strategy Our current strategic period started in 2021, setting out our vision and goals to achieve testing for healthy and safe lives.
G20 in India We are highlighting the importance of diagnostics in ensuring that the G20 health priorities are achieved.
100 Days Mission A plan for the world to be able to respond to and extinguish the global threat of the next Disease X within 100 days of WHO declaring a major outbreak or pandemic.
TESTED An exhibition about medical diagnosis, and why it matters that half the world has no access to testing.
Diagnostics & disease elimination Elimination of a disease as a public health problem refers to the reduction of the incidence or prevalence of a particular disease.
Press release Testing to combat antimicrobial resistance in low-resource settings gets US$10 million boost from extended FIND–GAMRIF partnership.
Featured opinion G20 presidency: fostering global collaboration to accelerate regional manufacturing for diagnostics
DxConnect Tools and resources provided under the DxConnect umbrella contain information managed and collated – but not owned – by FIND, as a service to the diagnostics community.
Data for decisions Diagnostics provide critical information for healthcare professionals, decision-makers, and people living with diseases and health conditions.
The diagnostic journey From R&D to implementation, the diagnostic value chain can be thought of as a journey of interconnected steps, or a "virtuous cycle".
Diagnostics Commission The Lancet Commission on diagnostics was published in 2021, putting forward recommendations to accelerate and transform access to diagnostics globally.
Announcements with IPPS and RBC made at the Diagnostics Dinner FIND calls for commitments to implement the WHA Resolution on diagnostics, signs an agreement with Rwanda Biomedical Centre and launches a new report on diagnostics for global health security FIND 29 Nov 2023
FIND and Rwanda Biomedical Centre sign agreement to support digitally enabled, equitable access to testing FIND & Rwanda Biomedical Centre 29 Nov 2023
Testing to combat antimicrobial resistance in low-resource settings gets US$10 million boost from extended FIND–GAMRIF partnership FINGAMRIF & FINDD 24 Nov 2023
African voices unite to drive cervical cancer elimination across the continent through new civil society coalition – ACHA ACHA, KILELE & FIND 15 Nov 2023
Diagnostics & the Nagoya Protocol The Nagoya protocol is an international agreement, supplementary to the United Nations Convention on Biological Diversity.
Diagnostics & disease elimination Elimination of a disease as a public health problem refers to the reduction of the incidence or prevalence of a particular disease or infection in a defined geographic area, as a result of deliberate efforts.
Diagnostics & trade finance Trade finance is a term that describes the financial instruments and products used by companies to facilitate international trade and commerce.
Diagnostics & intellectual property The pharmaceutical and vaccine industries both make regular use of patents to protect their innovative products. The situation for diagnostics is less straightforward; in many cases, patents are less consequential for diagnostics than for other health products.
Diagnostics & vaccines The benefits of vaccines are well known. However, vaccines cannot be developed, tested, targeted, or used efficiently and effectively without diagnostics. This document explains how diagnostics are a critical enabler for vaccines.
